Overview

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Status:
Completed

Trial end date:
2016-06-24

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD

Phase:

Phase 3

Details

Lead Sponsor:

Forest Laboratories

Collaborator:

Gedeon Richter Ltd.

Treatments:

Antidepressive Agents
Cariprazine